康龙“超车”药明,从礼来投资绑定开始!

盖德化工网
Mar 12

双方本质都是一体化CRDMO,随着康龙开始强化M端能力及M端业务的全面起航,龙大、龙二从R端到M端的“全盘较量”也许从这里才开始。礼来的橄榄枝,康龙化成“接住了”Guide View2026年3月11日,康龙化成与礼来公司共同宣布,达成关于首个申报注册的口服小分子GLP-1受体激动剂Orforglipron的生产合作协议。根据协议,礼来公司预期投资康龙化成2亿美元并支持其技术能力建设,未来将根据...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10